Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors
Open Access
Abstract
Malignant liver tumors include primary malignant liver tumors and liver metastases. They are among the most common malignancies worldwide. The disease has a poor prognosis and poor overall survival, especially with liver metastases. Therefore, early detection and differentiation between malignant liver tumors are critical for patient treatment selection. The detection of cancer and the prediction of its origin is possible with a DNA methylation profile of the tumor DNA compared to that of normal cells, which reflects tissue differentiation and malignant transformation. New technologies enable the characterization of the tumor methylome in circulating tumor DNA (ctDNA), providing a variety of new ctDNA methylation biomarkers, which can provide additional information to clinical decision-making. Our review of the literature provides insight into methylation changes in ctDNA from patients with common malignant liver tumors and can serve as a starting point for further research.Keywords
Funding Information
- The Slovenian Research and Innovation Agency (P3-0054, J3-3070)
This publication has 134 references indexed in Scilit:
- Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric CancerPLOS ONE, 2013
- Oxidative Damage Targets Complexes Containing DNA Methyltransferases, SIRT1, and Polycomb Members to Promoter CpG IslandsCancer Cell, 2011
- Distinct Profiles of Epigenetic Evolution between Colorectal Cancers with and without MetastasisThe American Journal of Pathology, 2011
- Methylation patterns in cell‐free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patientsInternational Journal of Cancer, 2010
- The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patientsJournal of Clinical Investigation, 2010
- Dna Hypomethylation In Cancer CellsEpigenomics, 2009
- DNA Methylation: Its Role in Cancer Development and TherapyCurrent Problems in Cancer, 2008
- Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic SilencingGastroenterology, 2007
- Is Liver Resection Justified for Patients With Hepatic Metastases From Breast Cancer?Annals of Surgery, 2006
- DNA methylation patterns and epigenetic memoryGenes & Development, 2002